Tadalafil Tablet
Product Images NDC 72789-184

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 72789-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789184 Label (72789184)

FDA Label Image

Figure8 (Tadalafil Fig8)

This text provides information about the results of a clinical trial evaluating the efficacy of Tadalafil 5mg compared to a placebo in patients with IPSS (International Prostate Symptom Score) Total Score. The results show a significant improvement with Tadalafil 5mg compared to placebo, marked by a change from baseline. However, the duration of treatment in weeks is not mentioned.*

FDA Label Image

Figure1 (Tadalafil Figure1)

FDA Label Image

Figure2 (Tadalafil Figure2)

FDA Label Image

Figure3 (Tadalafil Figure3)

Not available. The given text seems to be a table or a graph and does not contain any readable description to generate a useful response.*

FDA Label Image

Figure4 (Tadalafil Figure4)

FDA Label Image

Figure5 (Tadalafil Figure5)

FDA Label Image

Figure6 (Tadalafil Figure6)

FDA Label Image

Figure7 (Tadalafil Figure7)

FDA Label Image

Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.